C. Moglia

A. Chiò, A. Calvo, C. Moglia, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Monomelic amyotrophy is not always benign: A case report

A. Chiò, A. Calvo, C. Moglia, 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

THEME 8 CLINICAL IMAGING AND ELECTROPHYSIOLOGY IMG-01 First-recruited motor units adopt a faster phenotype in amyotrophic lateral sclerosis

A. Calvo, R. McMackin, B. Nasseroleslami, 2022 .

The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment

P. Lanteri, A. Chiò, A. Calvo, 2021, Neurobiology of Aging.

Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis

A. Chiò, G. Mora, G. Logroscino, 2018, European journal of neurology.

Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers

A. Chiò, A. Calvo, C. Moglia, 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations

A. Calvo, N. Stocchetti, A. Nobili, 2022, Frontiers in Immunology.

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic

Timothy A. Miller, Denis C. Bauer, Shankaracharya, 2018 .

Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis

A. Al-Chalabi, P. Andersen, A. Chiò, 2022, Neurobiology of Aging.

Erratum to: Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset

A. Chiò, F. Nobili, A. Calvo, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Religiousness is positively associated with quality of life of ALS caregivers

A. Chiò, A. Calvo, A. Montuschi, 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis

A. Chiò, G. Mora, A. Calvo, 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Cardiovascular diseases may play a negative role in the prognosis of ALS

Sonia, Messina, G. Mora, 2018 .

Assessment of the reliability of the motor unit size index (MUSIX) in single subject “round-robin” and multi-centre settings

M. Gaweł, E. Stålberg, M. Carvalho, 2019, Clinical Neurophysiology.

Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis

A. Al-Chalabi, P. Andersen, A. Chiò, 2022, Neurobiology of Aging.

A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms

P. Andersen, A. Chiò, G. Mora, 2018, Neurobiology of Aging.

A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment

A. Chiò, A. Calvo, M. Valentini, 2014, Journal of Neurology, Neurosurgery & Psychiatry.

Role of brain 2-[18F]fluoro-2-deoxy-D-glucose-positron-emission tomography as survival predictor in amyotrophic lateral sclerosis

A. Giuliani, A. Chiò, A. Calvo, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Respiratory support in a population-based ALS cohort: demographic, timing and survival determinants

A. Chiò, G. Mora, A. Calvo, 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

e-Pupil: IoT-Based Augmentative and Alternative Communication Device Exploiting the Pupillary Near-Reflex

S. Roatta, E. Patti, C. Moglia, 2022, IEEE Access.

Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study

A. Chiò, F. Nobili, M. Rizzone, 2019, Journal of Neurology.

Spatial epidemiology of amyotrophic lateral sclerosis in Piedmont and Aosta Valley, Italy: a population‐based cluster analysis

A. Chiò, A. Calvo, C. Moglia, 2018, European journal of neurology.

A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case

A. Chiò, B. Traynor, A. Calvo, 2014, Neurobiology of Aging.

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Ewout J. N. Groen, Annelot M. Dekker, Ross P. Byrne, 2021, Nature Genetics.

Genome-wide study of DNA methylation in Amyotrophic Lateral Sclerosis identifies differentially methylated loci and implicates metabolic, inflammatory and cholesterol pathways

Annelot M. Dekker, Ahmad Al Khleifat, N. Wray, 2021, medRxiv.

Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS

Annelot M. Dekker, N. Wray, A. McRae, 2022, Science Translational Medicine.

A novel splice site FUS mutation in a familial ALS case: effects on protein expression

A. Chiò, A. Calvo, C. Moglia, 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP‐43 subcellular distribution

A. Chiò, A. Calvo, M. Mostert, 2017, Neuropathology and applied neurobiology.

A de novo missense mutation of the FUS gene in a “true” sporadic ALS case

A. Chiò, B. Traynor, A. Calvo, 2011, Neurobiology of Aging.

Genetic correlation between amyotrophic lateral sclerosis and schizophrenia

Denis C. Bauer, Annelot M. Dekker, Ashley R. Jones, 2017, Nature Communications.

Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients

Janel O. Johnson, D. Hernandez, M. Nalls, 2010, Proceedings of the National Academy of Sciences.

Analysis of the GCG repeat length in NIPA1 gene in C9orf72-mediated ALS in a large Italian ALS cohort

A. Chiò, A. Calvo, C. Moglia, 2019, Neurological Sciences.

Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

Ewout J. N. Groen, Annelot M. Dekker, Ross P. Byrne, 2021, Nature Genetics.

Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene.

Janel O. Johnson, D. Hernandez, M. Nalls, 2011, Archives of neurology.

Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementia

A. Chiò, G. Mora, B. Traynor, 2020, bioRxiv.

Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis

Adriano Chiò, Flavio Nobili, Angelina Cistaro, 2016, Human brain mapping.

The role of peripheral immunity in ALS: a population‐based study

A. Chiò, A. Calvo, C. Moglia, 2022, medRxiv.

18F-FDG-PET correlates of cognitive impairment in ALS

A. Chiò, A. Calvo, A. Montuschi, 2016, Neurology.

Factors predicting disease progression in C9ORF72 ALS patients

M. Vinceti, A. Chiò, A. Calvo, 2022, Journal of Neurology.

Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis

A. Chiò, G. Mora, A. Calvo, 2021, Expert review of neurotherapeutics.

Common polymorphisms of chemokine (C‐X3‐C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population‐based study

A. Chiò, G. Mora, B. Traynor, 2018, Muscle & nerve.

The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients

A. Chiò, B. Traynor, F. Nobili, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Coffee and amyotrophic lateral sclerosis: a possible preventive role.

E. Beghi, G. Giussani, A. Chiò, 2011, American journal of epidemiology.

The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis

A. Chiò, A. Calvo, C. Moglia, 2020, Neurobiology of Aging.

Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis

Alessandro Bellini, Gianmario Sambuceti, Michele Piana, 2018, Brain : a journal of neurology.

A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis

Gianmario Sambuceti, Michele Piana, Annalisa Perasso, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Neurobehavioral symptoms in ALS are negatively related to caregivers’ burden and quality of life

A. Chiò, A. Calvo, A. Vignola, 2010, European journal of neurology.

Broadening the clinical spectrum of FUS mutations: a case with monomelic amyotrophy with a late progression to amyotrophic lateral sclerosis

A. Chiò, A. Calvo, C. Moglia, 2020, Neurological Sciences.

Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study

A. Chiò, A. Calvo, A. Facchin, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

ALS clinical trials

A. Chiò, G. Mora, A. Calvo, 2011, Neurology.

Causal associations of genetic factors with clinical progression in amyotrophic lateral sclerosis

M. Jahed-Motlagh, B. Minaei-Bidgoli, A. Chiò, 2022, Comput. Methods Programs Biomed..

Lithium carbonate in amyotrophic lateral sclerosis

E. Beghi, G. Logroscino, A. Chiò, 2010, Neurology.

Cognitive screening in patients with amyotrophic lateral sclerosis in early stages

A. Chiò, A. Calvo, A. Cannas, 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis

A. Chiò, A. Calvo, C. Moglia, 2018, European journal of neurology.

Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study.

A. Chiò, G. Mora, A. Calvo, 2014, JAMA neurology.

Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability

A. Chiò, G. Mora, A. Calvo, 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study

A. Chiò, A. Calvo, C. Moglia, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Pathogenic VCP Mutations Induce Mitochondrial Uncoupling and Reduced ATP Levels

Nick C Fox, Colin J. Mahoney, J. Hardy, 2013, Neuron.

The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis

M. Filippi, A. Calvo, R. Dubbioso, 2020, Journal of Neurology.

Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

E. Granieri, A. Chiò, G. Mora, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Serum chloride as a respiratory failure marker in amyotrophic lateral sclerosis

A. Chiò, A. Calvo, C. Moglia, 2023, Frontiers in Aging Neuroscience.

UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study

L. Ferrucci, A. Chiò, G. Mora, 2013, Neurobiology of Aging.

ATXN2 polyQ intermediate repeats are a modifier of ALS survival

A. Chiò, G. Mora, A. Calvo, 2015, Neurology.

Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without C9orf72 Mutation

A. Chiò, A. Calvo, C. Moglia, 2020, Neurology.

The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.

A. Chiò, A. Calvo, A. Montuschi, 2016, JAMA neurology.

HFE p.H63D polymorphism does not influence ALS phenotype and survival

Janel O. Johnson, M. Nalls, A. Chiò, 2015, Neurobiology of Aging.

Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis

A. Chiò, A. Calvo, C. Moglia, 2020, European journal of neurology.

Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience

A. Chiò, A. Calvo, C. Moglia, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

C9orf72 ALS mutation carriers show extensive cortical and subcortical damage compared to matched wild-type ALS patients

A. Chiò, F. Agosta, A. Calvo, 2023, NeuroImage: Clinical.

Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study

A. Chiò, G. Mora, A. Calvo, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

Anxiety undermines quality of life in ALS patients and caregivers

A. Chiò, A. Calvo, A. Vignola, 2008, European journal of neurology.

Multicentre, cross-cultural, population-based, case–control study of physical activity as risk factor for amyotrophic lateral sclerosis

R. Vermeulen, E. Beghi, A. Chiò, 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression

R. Rinaldi, B. Di Camillo, M. Vinceti, 2022, Journal of Neurology.

Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study

L. Pozzi, M. Filippi, A. Chiò, 2020, Journal of Neurology, Neurosurgery, and Psychiatry.

Comorbidity of dementia with amyotrophic lateral sclerosis (ALS): insights from a large multicenter Italian cohort

A. Chiò, G. Mora, G. Logroscino, 2017, Journal of Neurology.

Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicenter Italian study

Messina, Lunetta, L. Pozzi, 2020 .

Non-Invasive Mechanical Ventilation reduces the Motor Decline in Amyotrophic Lateral Sclerosis

A. Chiò, G. Mora, A. Calvo, 2023, medRxiv.

Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions

A. Chiò, G. Mora, A. Calvo, 2023, European journal of neurology.

Brain metabolic differences between pure bulbar and pure spinal ALS: a 2-[18F]FDG-PET study

A. Giuliani, A. Chiò, A. Calvo, 2022, Journal of Neurology.

Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study

A. Chiò, P. van Damme, K. Van Laere, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Validation of the Italian version of self-administered ALSFRS-R scale

A. Chiò, A. Calvo, C. Moglia, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis

A. Chiò, G. Mora, B. Traynor, 2023, Neurology.

Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis

Sonja W. Scholz, A. Chiò, B. Traynor, 2022, Neurology: Genetics.

Validation of the revised classification of cognitive and behavioural impairment in ALS

A. Chiò, G. Mora, A. Calvo, 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study

A. Chiò, G. Mora, A. Calvo, 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study.

M. Nalls, Anant Dadu, F. Faghri, 2022, The Lancet. Digital health.

Identification and prediction of ALS subgroups using machine learning

M. Nalls, R. Campbell, Anant Dadu, 2021, medRxiv.

Structural and functional brain connectome in motor neuron diseases

M. Filippi, A. Falini, A. Chiò, 2020, Neurology.

Quality Control of Motor Unit Number Index (MUNIX) Measurements in 6 Muscles in a Single-Subject “Round-Robin” Setup

Christian Burkhardt, Cristina Moglia, Maarten Schrooten, 2016, PloS one.

Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort

Sonja W. Scholz, A. Chiò, B. Traynor, 2020, Neurology.

Amyotrophic lateral sclerosis mimic syndrome due to a dorsal spinal cord neurofibroma

A. Chiò, R. Mutani, A. Calvo, 2010, Neurological Sciences.

TBK1 is associated with ALS and ALS-FTD in Sardinian patients

Hannah A. Pliner, A. Mulas, F. Marrosu, 2016, Neurobiology of Aging.

GBA variants influence cognitive status in amyotrophic lateral sclerosis

A. Chiò, B. Traynor, A. Calvo, 2021, Journal of Neurology, Neurosurgery, and Psychiatry.

Theme 10 - Disease Stratification and Phenotyping of Patients

A. Chiò, A. Calvo, C. Moglia, 2022, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration.

Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

Ryan L. Collins, Sonja W. Scholz, Toshiko Tanaka, 2023, Cell genomics.

Plasma CHI3L1 in Amyotrophic Lateral Sclerosis: A Potential Differential Diagnostic Biomarker

A. Chiò, A. Calvo, C. Moglia, 2023, Journal of clinical medicine.

Editorial: Non-motor Symptoms in Primary Motor Neurological Disorders: From Molecular Pathways to Clinical and Therapeutic Implications

K. E. Ehgoetz Martens, F. Christidi, C. Moglia, 2019, Front. Neurosci..

Prognostic role of slow vital capacity in amyotrophic lateral sclerosis

A. Chiò, A. Calvo, C. Moglia, 2020, Journal of Neurology.

Amyotrophic Lateral Sclerosis OutcomeMeasures and the Role of Albumin and Creatinine A Population-Based Study

A. Chiò, G. Mora, A. Calvo, 2014 .

Case report: p.Glu134del SOD1 mutation in two apparently unrelated ALS patients with mirrored phenotype

C. Moglia, E. Zucchi, I. Martinelli, 2023, Frontiers in Neurology.

The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations

A. Chiò, V. Meininger, G. Mora, 2023, Biomedicines.

Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey.

A. Calvo, S. Veronese, C. Moglia, 2023, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor

A. Chiò, A. Calvo, C. Moglia, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course

A. Chiò, A. Calvo, C. Moglia, 2015, Amyotrophic lateral sclerosis & frontotemporal degeneration.

The multistep hypothesis of ALS revisited The role of genetic mutations

N. Pearce, A. Chiò, O. Hardiman, 2022 .

The multistep hypothesis of ALS revisited The role of genetic mutations

A. Chiò, O. Hardiman, R. McLaughlin, 2022 .

Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic

A. Chiò, A. Calvo, C. Moglia, 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Brain 18fluorodeoxyglucose-positron emission tomography changes in amyotrophic lateral sclerosis with TARDBP mutations

A. Chiò, A. Calvo, C. Moglia, 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

Cognitive Reserve in ALS with Comorbid Frontotemporal Dementia (FTD): A Population-Based Study (P5.081)

A. Chiò, L. Lopiano, A. Calvo, 2014 .

Plateaus in amyotrophic lateral sclerosis progression: results from a population‐based cohort

A. Chiò, A. Calvo, C. Moglia, 2020, European journal of neurology.

THEME 2 GENETICS AND GENOMICS GEN-01 A case of an uncommon late onset of ALS associated with an undescribed SOD1 mutation GEN-02 A novel mutation in ZFYVE26 gene (c.195-1G > A) in a young man affected by spastic paraplegia

A. Calvo, G. Siciliano, A. Fogli, 2022 .

ALS clinical trials

A. Chiò, G. Mora, A. Calvo, 2011, Neurology.

Pain in amyotrophic lateral sclerosis: a population‐based controlled study

A. Chiò, A. Calvo, C. Moglia, 2012, European journal of neurology.

Repeated courses of granulocyte colony‐stimulating factor in amyotrophic lateral sclerosis: Clinical and biological results from a prospective multicenter study

A. Chiò, G. Mora, S. Rutella, 2011, Muscle & nerve.

ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry

M. Nalls, F. Marrosu, A. Chiò, 2015, Neurobiology of Aging.

Influence of cigarette smoking on ALS outcome: a population-based study

A. Chiò, G. Mora, A. Calvo, 2016, Journal of Neurology, Neurosurgery & Psychiatry.

Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis

A. Chiò, A. Calvo, C. Moglia, 2023, Journal of Neurology.

Theme 02 - Genetics and Genomics

A. Calvo, G. Siciliano, A. Fogli, 2022, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis?

A. Chiò, A. Calvo, C. Moglia, 2021, Journal of the Neurological Sciences.

Theme 08 - CLINICAL IMAGING AND ELECTROPHYSIOLOGY

T. Williams, A. Calvo, R. McMackin, 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries

M. Vinceti, A. Chiò, A. Calvo, 2023, Journal of Neurology.

Genetic architecture of ALS in Sardinia

Hannah A. Pliner, M. Nalls, F. Marrosu, 2014, Neurobiology of Aging.

A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD

A. Chiò, B. Traynor, A. Calvo, 2011, Neurobiology of Aging.

Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis

Annelot M. Dekker, Raymond D. Schellevis, Ashley R. Jones, 2016, Nature Genetics.

Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis

A. Al-Chalabi, P. Andersen, A. Chiò, 2022, Neurobiology of Aging.

Neurobiology of Aging

J. Veldink, A. Calvo, C. Moglia, 2022 .

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis

Hannah A. Pliner, John D. Eicher, Janel O. Johnson, 2021, JAMA Neurology.

Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson’s Disease Unveiled in Peripheral Blood Mononuclear Cells

M. Rizzone, L. Lopiano, A. Calvo, 2023, ACS chemical neuroscience.

Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosis.

C. Moglia, U. Manera, A. Canosa, 2024, Journal of neurology, neurosurgery, and psychiatry.